BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37945587)

  • 21. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
    Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
    PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-associated gastric cancer: disease that requires special approach.
    Ignatova E; Seriak D; Fedyanin M; Tryakin A; Pokataev I; Menshikova S; Vakhabova Y; Smirnova K; Tjulandin S; Ajani JA
    Gastric Cancer; 2020 Nov; 23(6):951-960. PubMed ID: 32514646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions.
    Sasaki S; Nishikawa J; Sakai K; Iizasa H; Yoshiyama H; Yanagihara M; Shuto T; Shimokuri K; Kanda T; Suehiro Y; Yamasaki T; Sakaida I
    Gastric Cancer; 2019 May; 22(3):486-496. PubMed ID: 30264329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
    Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
    Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
    Seo AN; Kang BW; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Bae HI; Jeon SW; Kang H; Kim JG
    Br J Cancer; 2017 Dec; 117(12):1753-1760. PubMed ID: 29073638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
    Liu S; Zhao Z; Han L; Liu S; Luo B
    PLoS One; 2016; 11(2):e0148342. PubMed ID: 26859565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
    Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
    Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regional distribution and clinicopathological characteristics of Epstein-Barr virus associated gastric cancer].
    Hu CF; Lin H; Chen YJ; Dai HT; Wang BZ; Xue LY
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):943-948. PubMed ID: 33256306
    [No Abstract]   [Full Text] [Related]  

  • 32. Epstein-Barr Virus and PD-L1 in Esophageal and Esophagogastric Junction Cancer: Differences According to Location and Histological Type.
    Ribeiro MB; Marques SB; Soares IC; Pereira MA; Takeda FR; Safatle-Ribeiro AV; Ribeiro U
    J Gastrointest Surg; 2022 Nov; 26(11):2358-2364. PubMed ID: 35668227
    [No Abstract]   [Full Text] [Related]  

  • 33. Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1
    Saito R; Abe H; Kunita A; Yamashita H; Seto Y; Fukayama M
    Mod Pathol; 2017 Mar; 30(3):427-439. PubMed ID: 27934877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma.
    Kondo A; Shinozaki-Ushiku A; Rokutan H; Kunita A; Ikemura M; Yamashita H; Seto Y; Nagae G; Tatsuno K; Aburatani H; Koinuma D; Ushiku T
    J Pathol; 2023 Jun; 260(2):124-136. PubMed ID: 36806225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
    Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
    Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion.
    Salnikov M; Prusinkiewicz MA; Lin S; Ghasemi F; Cecchini MJ; Mymryk JS
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.
    Yoshiwara E; Koriyama C; Akiba S; Itoh T; Minakami Y; Chirinos JL; Watanabe J; Takano J; Miyagui J; Hidalgo H; Chacon P; Linares V; Eizuru Y
    J Exp Clin Cancer Res; 2005 Mar; 24(1):49-54. PubMed ID: 15943031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma.
    Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK
    Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
    Kawazoe A; Shitara K; Kuboki Y; Bando H; Kojima T; Yoshino T; Ohtsu A; Ochiai A; Togashi Y; Nishikawa H; Doi T; Kuwata T
    Gastric Cancer; 2019 Jan; 22(1):69-76. PubMed ID: 29859006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.